Immunogenicity of low dose prime-boost vaccination of mRNA vaccine CV07050101 in non-human primates

Many different vaccine candidates against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the etiological agent of COVID-19, are currently approved and under development. Vaccine platforms vary from mRNA vaccines to viral-vectored vaccines, and several candidates have been shown to pro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:bioRxiv
Main Authors: van Doremalen, Neeltje, Fischer, Robert J., Schulz, Jonathan E., Holbrook, Myndi G., Smith, Brian J., Lovaglio, Jamie, Petsch, Benjamin, Munster, Vincent J.
Formato: Artigo
Idioma:Inglês
Publicado em: Cold Spring Harbor Laboratory 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8282095/
https://ncbi.nlm.nih.gov/pubmed/34268507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.07.07.451505
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados